63071-12-5

Basic information

• Product Name: (6-METHOXY-PYRIDIN-2-YL)-METHANOL
• Synonyms: (6-METHOXY-PYRIDIN-2-YL)-METHANOL;Zinc04352715;6-Methoxy-2-PyridineMethanol;2-Pyridinemethanol,6-methoxy-
• CAS NO: 63071-12-5
• Molecular Formula: C₇H₉NO₂
• Molecular Weight: 139.15
• Mol File: 63071-12-5.mol
• Article Data: 18

Chemical Properties

• Boiling Point: 235.3°C at 760 mmHg
• Flash Point: 96.1°C
• Appearance: /
• Density: 1.155g/cm³
• Vapor Pressure: 0.0278mmHg at 25°C
• Refractive Index: 1.534
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 13.22±0.10(Predicted)
• CAS DataBase Reference: (6-METHOXY-PYRIDIN-2-YL)-METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (6-METHOXY-PYRIDIN-2-YL)-METHANOL(63071-12-5)
• EPA Substance Registry System: (6-METHOXY-PYRIDIN-2-YL)-METHANOL(63071-12-5)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 63071-12-5(Hazardous Substances Data)

Usage

General Description

"(6-Methoxy-pyridin-2-yl)-methanol" is a chemical compound with a molecular formula C7H9NO2, signifying seven carbon atoms, nine hydrogen atoms, one nitrogen atom, and two oxygen atoms in each molecule. (6-METHOXY-PYRIDIN-2-YL)-METHANOL belongs to the class of organic compound known as pyridinylmethanols, which consist of a methanol substructure linked to a pyridine ring. It has not been widely studied, so the information about its properties, uses, effects on human health or the environment may not be readily available. However, its basic existence as an organic compound with a pyridine ring could suggest potential utility in medicinal chemistry or other scientific applications.

InChI:InChI=1/C7H9NO2/c1-10-7-4-2-3-6(5-9)8-7/h2-4,9H,5H2,1H3

Upstream product

• 107465-28-1 7-methoxytriazolopyridine 
• 19621-92-2 6-Hydroxypicolinic acid 
• 67-56-1 methanol 
• 40473-07-2 6-bromo-2-methoxypyridine 
• 54221-96-4 6-methoxypyridine-2-carbaldehyde 
• 83621-01-6 2-cyano-6-methoxypyridine 
• 26893-73-2 6-methoxypyridine-2-carboxylic acid 
• 68-12-2 N,N-dimethyl-formamide 
• 26256-72-4 6-methoxy-pyridine-2-carboxylic acid methyl ester 
• 77134-17-9 7-lithiotriazolopyridine 
• 107465-26-9 7-bromo-[1,2,3]triazolo[1,5-a]pyridine 

Downstream Products

• 1270038-11-3 methyl 3-(3-[2-({(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)-6-methoxypyridin-3-yl]-4-methoxyphenyl)propanoate 
• 1270038-08-8 3-{3-[2-({(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)-6-methoxypyridin-3-yl]-4-methoxyphenyl}propanoic acid 
• 1270038-12-4 C₁₈H₂₁NO₅ 
• 1270038-13-5 C₁₈H₂₀ClNO₄ 
• 156094-63-2 2-(bromomethyl)-6-methoxypyridine 
• 1000512-48-0 2‐(6‐methoxypyridin‐2‐yl)acetonitrile 
• 54221-96-4 6-methoxypyridine-2-carbaldehyde 
• 864264-99-3 2-(chloromethyl)-6-methoxypyridine hydrochloride 
• 1215282-06-6 3-{3-[(4-chlorophenyl)carbonyl]-1-(2,2-dimethylpropanoyl)-7-[(6-methoxypyridin-2-yl)methoxy]indolizin-2-yl}-2,2-dimethylpropanoic acid 
• 1361225-15-1 ethyl N-(diphenylmethylidene)-3-(6-methoxy-2-pyridinyl)alaninate 
• 1361225-14-0 1,1,1,3,3,3-hexafluoro-2-(4-(2-((6-methoxy-2-pyridinyl)methyl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol 
• 1215284-26-6 ethyl 3-{3-[(4-chlorophenyl)carbonyl]-1-(2,2-dimethylpropanoyl)-7-[(6-methoxypyridin-2-yl)methoxy]indolizin-2-yl}-2,2-dimethylpropanoate 
• 1301168-23-9 2-[4-[1-(2-fluoroethyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxymethyl]-6-methoxypyridine succinic acid 
• 405103-68-6 2-(chloromethyl)-6-methoxypyridine 

Relevant articles and documents

PYRIMIDINYL GROUP-CONTAINING TRICYCLIC COMPOUND SERVING AS C-MET INHIBITOR

Disclosed are a pyrimidinyl group-containing tricyclic compound and applications thereof in preparing a cancer-treating medicament. Specifically disclosed are a compound as represented by formula (I), a pharmaceutically acceptable salt of same, or an isomer thereof.

OX2R COMPOUNDS

Methods and compositions for agonizing a type-2 orexin receptor (OX2R) in a cell determined to be in need thereof, including the general method of (a) administering to a subject a cyclic guanidinyl OX2R agonist and (b) detecting a resultant enhanced wakefulness or increased resistance to diet-induced accumulation of body fat, or abbreviated recovery from general anesthesia or jet lag.

Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof

The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.